These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28853699)

  • 1. Successful therapy with mycophenolic acid in a membranous glomerulonephritis due to Kimura disease
.
    Gaillard J; Rotman S; Girardet C; Spertini F
    Clin Nephrol; 2017 Oct; 88(10):221-225. PubMed ID: 28853699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological features and prognosis of Kimura's disease with renal involvement in Chinese patients.
    Chen Y; Wang J; Xu F; Zeng C; Liu Z
    Clin Nephrol; 2016 Jun; 85(6):332-9. PubMed ID: 27142199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Mycophenolate Mofetil versus Cyclosporine as Combination Therapy with Low Dose Corticosteroids in High-risk Patients with Idiopathic Membranous Nephropathy: a Multicenter Randomized Trial.
    Choi JY; Kim DK; Kim YW; Yoo TH; Lee JP; Chung HC; Cho KH; An WS; Lee DH; Jung HY; Cho JH; Kim CD; Kim YL; Park SH
    J Korean Med Sci; 2018 Feb; 33(9):e74. PubMed ID: 29441742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of mycophenolate mofetil in resistant membranous nephropathy.
    Miller G; Zimmerman R; Radhakrishnan J; Appel G
    Am J Kidney Dis; 2000 Aug; 36(2):250-6. PubMed ID: 10922302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent Kidney Glomerular and Interstitial Lesions Associated with Kimura's Disease.
    Yang S; Wang J; Chen Y; Jiang Z; Zhong T; Dong Y; Guan W; Chen W
    Nephron; 2019; 143(2):92-99. PubMed ID: 31387106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful mycophenolate mofetil treatment of glomerular disease.
    Briggs WA; Choi MJ; Scheel PJ
    Am J Kidney Dis; 1998 Feb; 31(2):213-7. PubMed ID: 9469489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil in treatment of idiopathic stages III-IV membranous nephropathy.
    Polenakovic M; Grcevska L; Dzikova S
    Nephrol Dial Transplant; 2003 Jun; 18(6):1233-4. PubMed ID: 12748370
    [No Abstract]   [Full Text] [Related]  

  • 8. Thrombosis of temporal artery and renal vein in Kimura-disease-related nephrotic syndrome.
    Danis R; Ozmen S; Akin D; Ozekinci S; Altintas A; Cil T; Pasa S; Kilinc I
    J Thromb Thrombolysis; 2009 Jan; 27(1):115-8. PubMed ID: 18066701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of membranous nephropathy with Kimura's disease.
    Yi F; Jiang J; Li J; Lan L
    Clin Nephrol; 2022 Mar; 97(3):183-187. PubMed ID: 34889731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Kimura's disease associated with extracapillary glomerulonephritis].
    Chauvel C; Valeyrie-Allanore L; Essig M; Vrtovsnik F; Walker F; Marinho E; Maubec E; Descamps V; Crickx B
    Ann Dermatol Venereol; 2006; 133(8-9 Pt 1):689-92. PubMed ID: 17053740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil monotherapy in membranous nephropathy: a 1-year randomized controlled trial.
    Dussol B; Morange S; Burtey S; Indreies M; Cassuto E; Mourad G; Villar E; Pouteil-Noble C; Karaaslan H; Sichez H; Lasseur C; Delmas Y; Nogier MB; Fathallah M; Loundou A; Mayor V; Berland Y
    Am J Kidney Dis; 2008 Oct; 52(4):699-705. PubMed ID: 18585835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective controlled study on mycophenolate mofetil and prednisolone in the treatment of membranous nephropathy with nephrotic syndrome.
    Chan TM; Lin AW; Tang SC; Qian JQ; Lam MF; Ho YW; Tse KC; Chan KW; Lai KN; Tang CS
    Nephrology (Carlton); 2007 Dec; 12(6):576-81. PubMed ID: 17995584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of proteinuria with mycophenolate mofetil in predominantly membranous lupus nephropathy.
    Karim MY; Pisoni CN; Ferro L; Tungekar MF; Abbs IC; D'Cruz DP; Khamashta MA; Hughes GR
    Rheumatology (Oxford); 2005 Oct; 44(10):1317-21. PubMed ID: 16049051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kimura disease: a case report and review of the Chinese literature.
    Wang DY; Mao JH; Zhang Y; Gu WZ; Zhao SA; Chen YF; Liu AM
    Nephron Clin Pract; 2009; 111(1):c55-61. PubMed ID: 19052471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of different therapies in high-risk patients with idiopathic membranous nephropathy.
    Peng L; Wei SY; Li LT; He YX; Li B
    J Formos Med Assoc; 2016 Jan; 115(1):11-8. PubMed ID: 26315481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycophenolate mofetil as the primary treatment of membranous lupus nephritis with and without concurrent proliferative disease: a retrospective study of 29 cases.
    Kasitanon N; Petri M; Haas M; Magder LS; Fine DM
    Lupus; 2008 Jan; 17(1):40-5. PubMed ID: 18089682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive treatment for pure membranous lupus nephropathy in a Hispanic population.
    Mejía-Vilet JM; Córdova-Sánchez BM; Uribe-Uribe NO; Correa-Rotter R
    Clin Rheumatol; 2016 Sep; 35(9):2219-27. PubMed ID: 27475791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil therapy in children with idiopathic membranous nephropathy.
    Bhimma R; Naicker E; Ramdial PK
    Clin Nephrol; 2013 Dec; 80(6):441-8. PubMed ID: 24262490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil in the treatment of glomerular diseases.
    Grcevska L; Polenakovic M
    Prilozi; 2007 Jul; 28(1):57-68. PubMed ID: 17921918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-dose Rituximab Therapy for Refractory Idiopathic Membranous Nephropathy: A Single-center Experience.
    Katsuno T; Ozaki T; Kim H; Kato N; Suzuki Y; Akiyama S; Ishimoto T; Kosugi T; Tsuboi N; Ito Y; Maruyama S
    Intern Med; 2017; 56(13):1679-1686. PubMed ID: 28674357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.